carbidopa, levodopa drug combination has been researched along with Chronic Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hurka, MR; Leopold, NA; Polansky, M | 1 |
| Elias, JW; Hutton, JT; Imke, SC; Morris, JL; Román, GC | 1 |
| Adamkov, J; Fundárek, J; Sútorová, D | 1 |
| Ballard, PA; Langston, JW; Tetrud, JW | 1 |
1 trial(s) available for carbidopa, levodopa drug combination and Chronic Disease
| Article | Year |
|---|---|
Treatment of chronic Parkinson's disease with controlled-release carbidopa/levodopa.
Topics: Aged; Carbidopa; Chronic Disease; Delayed-Action Preparations; Disability Evaluation; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1988 |
3 other study(ies) available for carbidopa, levodopa drug combination and Chronic Disease
| Article | Year |
|---|---|
Drug adherence in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Chronic Disease; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Female; Humans; Levodopa; Male; Medication Systems; Parkinson Disease; Patient Compliance; Surveys and Questionnaires | 2004 |
[Neurologic and electromyographic findings in chronic manganese encephalopathy].
Topics: Adult; Brain Diseases; Carbidopa; Chronic Disease; Drug Combinations; Electromyography; Humans; Levodopa; Male; Manganese Poisoning; Metallurgy; Middle Aged; Occupational Diseases | 1986 |
Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acute Disease; Adult; Carbidopa; Chronic Disease; Drug Combinations; Female; Humans; Levodopa; Male; Parkinson Disease; Pyridines; Substance-Related Disorders; Substantia Nigra | 1985 |